FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Green

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
B M Syed; Ian O Ellis; J Garibaldi; Andrew Green; D A L Morgan; L Morgan; E C Paish; D Soria; Kwok-Leung Cheung
Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
A J Agboola; B A Ayoade; A A F Banjo; A M Deji-Agboola; Andrew Green; A A Musa; C C Nolan; T Y Oyebadejo; Emad A Rakha; N Wanangwa; T Abdel-Fatah; Ian O Ellis
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Sahar MA Mahmoud; E Claire Paish; Ian O Ellis; A H S Lee; R Douglas Macmillan; Andrew Green
The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Green (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: B M Syed; Ian O Ellis; J Garibaldi; Andrew Green; D A L Morgan; L Morgan; E C Paish; D Soria; Kwok-Leung Cheung
Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
British journal of cancer 2013;108(5):1042-51.
2012: A J Agboola; B A Ayoade; A A F Banjo; A M Deji-Agboola; Andrew Green; A A Musa; C C Nolan; T Y Oyebadejo; Emad A Rakha; N Wanangwa; T Abdel-Fatah; Ian O Ellis
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Breast cancer research and treatment 2012;135(2):555-69.
2012: Sahar MA Mahmoud; E Claire Paish; Ian O Ellis; A H S Lee; R Douglas Macmillan; Andrew Green
The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
Breast cancer research and treatment 2012;132(2):545-53.
2012: Sahar MA Mahmoud; E Claire Paish; Ian O Ellis; A H S Lee; R Douglas Macmillan; Andrew Green
Tumour-infiltrating macrophages and clinical outcome in breast cancer.
Journal of clinical pathology 2012;65(2):159-63.
2011: Des G Powe; M J Voss; K S Zänker; Ian O Ellis; Andrew Green; H O Habashy; Frank Entschladen
Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Breast cancer research and treatment 2011;130(2):457-63.
2011: B M Syed; W Al-Khyatt; S J Johnston; D W M Wong; L Winterbottom; H Kennedy; Andrew Green; D A L Morgan; Ian O Ellis; Kwok-Leung Cheung
Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.
British journal of cancer 2011;104(9):1393-400.
2011: Aleksandra Filipović; Julian Hendrik Gronau; Andrew Green; Jayson Wang; Sabari Vallath; Dongmin Shao; Sabeena Rasul; Ian O Ellis; Ernesto Yagüe; Justin Sturge; R Charles Coombes
Biological and clinical implications of nicastrin expression in invasive breast cancer.
Breast cancer research and treatment 2011;125(1):43-53.
2010: Tarek M A Abdel-Fatah; Des G Powe; Graham Ball; Maria A Lopez-Garcia; Hany O Habashy; Andrew Green; Jorge S Reis-Filho; Ian O Ellis
Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.
The Journal of pathology 2010;222(4):388-99.
2010: Emad A Rakha; Arjun Patel; Des G Powe; Ahmed Benhasouna; Andrew Green; Maryou B K Lambros; Jorge S Reis-Filho; Ian O Ellis
Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.
The American journal of surgical pathology 2010;34(10):1472-9.
2010: S-J Dawson; N Makretsov; F M Blows; K E Driver; E Provenzano; John Le Quesne; L Baglietto; G Severi; G G Giles; C A McLean; G Callagy; Andrew Green; I Ellis; K Gelmon; G Turashvili; S Leung; S Aparicio; D Huntsman; C Caldas; P Pharoah
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.
British journal of cancer 2010;103(5):668-75.
2010: T'ng Chang Kwok; Emad A Rakha; Andrew H S Lee; Matthew Grainge; Andrew Green; Ian O Ellis; Desmond G Powe
Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation.
Histopathology 2010;57(2):212-9.
2010: Mohammed Aleskandarany; Emad A Rakha; Mohamed A H Ahmed; Des G Powe; Emma C Paish; R Douglas Macmillan; Ian O Ellis; Andrew Green
PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
Breast cancer research and treatment 2010;122(1):45-53.
2010: Fiona M Blows; Kristy E Driver; Marjanka K Schmidt; Annegien Broeks; Flora E van Leeuwen; Jelle Wesseling; Maggie C Cheang; Karen Gelmon; Torsten O Nielsen; Carl Blomqvist; Päivi Heikkilä; Tuomas Heikkinen; Heli Nevanlinna; Lars A Akslen; Louis R Bégin; William D Foulkes; Fergus J Couch; Xianshu Wang; Vicky Cafourek; Janet E Olson; Laura Baglietto; Graham G Giles; Gianluca Severi; Catriona A McLean; Melissa C Southey; Emad Rakha; Andrew Green; Ian O Ellis; Mark E Sherman; Jolanta Lissowska; William F Anderson; Angela Cox; Simon S Cross; Malcolm W R Reed; Elena Provenzano; Sarah-Jane Dawson; Alison M Dunning; Manjeet Humphreys; Douglas F Easton; Montserrat García-Closas; Carlos Caldas; Paul D Pharoah; David Huntsman
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
PLoS medicine 2010;7(5):e1000279.
2010: H Zhang; Emad A Rakha; G R Ball; I Spiteri; Mohammed Aleskandarany; E C Paish; Des G Powe; R D Macmillan; C Caldas; Ian O Ellis; Andrew Green
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Breast cancer research and treatment 2010;121(1):41-51.
2010: Fabrício F T Barros; Desmond G Powe; Ian O Ellis; Andrew Green
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments.
Histopathology 2010;56(5):560-72.
2010: Mohammed Aleskandarany; Andrew Green; Emad A Rakha; Rabab A Mohammed; Somaia E Elsheikh; Des G Powe; Emma C Paish; R Douglas Macmillan; Steve Chan; Samreen I Ahmed; Ian O Ellis
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.
International journal of cancer. Journal international du cancer 2010;126(7):1761-9.
2010: Hany Onsy Habashy; Des G Powe; Emad A Rakha; Graham Ball; R Douglas Macmillan; Andrew Green; Ian O Ellis
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.
Breast cancer research and treatment 2010;120(3):603-12.
2010: Tomás García-Caballero; Dorthe Grabau; Andrew Green; John Gregory; Arno Schad; Elke Kohlwes; Ian O Ellis; Sarah Watts; Jens Mollerup
Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens.
Histopathology 2010;56(4):472-80.
2010: Daniele Soria; Jonathan M Garibaldi; Federico Ambrogi; Andrew Green; Des Powe; Emad Rakha; R Douglas Macmillan; Roger W Blamey; Graham Ball; Paulo J G Lisboa; Terence A Etchells; Patrizia Boracchi; Elia Biganzoli; Ian O Ellis
A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients.
Computers in biology and medicine 2010;40(3):318-30.
2010: Tarek M Abdel-Fatah; Des G Powe; Johnson Agboola; Martyna Adamowicz-Brice; Roger W Blamey; Maria A Lopez-Garcia; Andrew Green; Jorge S Reis-Filho; Ian O Ellis
The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.
The Journal of pathology 2010;220(4):419-34.
2010: Lee Lancashire; D G Powe; Jorge S Reis-Filho; E Rakha; C Lemetre; B Weigelt; T M Abdel-Fatah; Andrew Green; R Mukta; R Blamey; E C Paish; R C Rees; Ian O Ellis; G R Ball
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks.
Breast cancer research and treatment 2010;120(1):83-93.
2010: Hany Onsy Habashy; Des G Powe; Cindy M Staka; Emad A Rakha; Graham Ball; Andrew Green; Mohammed Aleskandarany; E Claire Paish; R Douglas Macmillan; Robert I Nicholson; Ian O Ellis; Julia M W Gee
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Breast cancer research and treatment 2010;119(2):283-93.
2009: Sarah Doyle; Andrew J Evans; Emad A Rakha; Andrew Green; Ian O Ellis
Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening.
Radiology 2009;253(1):51-5.
2009: G Okunade; Andrew Green; M Ying; A Agrawal; E C Paish; Mohammed Aleskandarany; L Winterbottom; K Hassell; D A L Morgan; Ian O Ellis; K L Cheung
Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
Critical reviews in oncology/hematology 2009;72(1):76-82.
2009: I T H Au-Yong; Andrew J Evans; S Taneja; E A Rakha; Andrew Green; Claire E Paish; Ian O Ellis
Sonographic correlations with the new molecular classification of invasive breast cancer.
European radiology 2009;19(10):2342-8.
2009: E Claire Paish; Andrew Green; Emad A Rakha; R Douglas Macmillan; J R Maddison; Ian O Ellis
Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth.
Journal of clinical pathology 2009;62(7):617-23.
2009: S M Khoshnaw; Andrew Green; Desmond G Powe; Ian O Ellis
MicroRNA involvement in the pathogenesis and management of breast cancer.
Journal of clinical pathology 2009;62(5):422-8.
2009: Somaia E Elsheikh; Andrew Green; Emad A Rakha; Des G Powe; Rabab A Ahmed; Hilary M Collins; Daniele Soria; Jonathan M Garibaldi; Claire E Paish; Amr A Ammar; Matthew J Grainge; Graham R Ball; Magdy K Abdelghany; Luisa Martinez-Pomares; David M Heery; Ian O Ellis
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Cancer research 2009;69(9):3802-9.
2009: Emad A Rakha; Somaia E Elsheikh; Mohammed Aleskandarany; Hany O Habashi; Andrew Green; Desmond G Powe; Maysa E El-Sayed; Ahmed Benhasouna; Jean-Sebastien Brunet; Lars A Akslen; Andy J Evans; Roger Blamey; Jorge S Reis-Filho; William D Foulkes; Ian O Ellis
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2302-10.
2009: Andrew Green; Peter Young; Sophie Krivinskas; Emad A Rakha; E Claire Paish; Desmond G Powe; Ian O Ellis
The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Histopathology 2009;54(4):419-27.
2009: Des G Powe; Gulfareen Akhtar; Hany Onsy Habashy; Tarek Abdel-Fatah; Emad A Rakha; Andrew Green; Ian O Ellis
Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.
Breast cancer research : BCR 2009;11(6):R90.
2009: Mark R Pickard; Andrew Green; Ian O Ellis; Carlos Caldas; VL Hedge; Mirna Mourtada-Maarabouni; Gwyn T Williams
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
Breast cancer research : BCR 2009;11(4):R60.
2009: Andrew Green; Sophie Krivinskas; Peter Young; Emad A Rakha; E Claire Paish; Desmond G Powe; Ian O Ellis
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Breast cancer research and treatment 2009;113(1):59-66.
2008: Valerie Speirs; Andrew Green; Thomas A Hughes; Ian O Ellis; Philippa Saunders; Abeer M Shaaban
Clinical importance of estrogen receptor beta isoforms in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5825; author reply 5825-6.
2008: S Taneja; Andrew J Evans; Emad A Rakha; Andrew Green; G Ball; Ian O Ellis
The mammographic correlations of a new immunohistochemical classification of invasive breast cancer.
Clinical radiology 2008;63(11):1228-35.
2008: Lucy R Webster; Shu-Fen Lee; Clare Ringland; Adrienne L Morey; Andrew M Hanby; Graeme Morgan; Karen Byth; Patricia A Mote; Pamela J Provan; Ian O Ellis; Andrew Green; Gillian Lamoury; Peter M Ravdin; Christine L Clarke; Robyn L Ward; Rosemary L Balleine; Nicholas J Hawkins
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6625-33.
2008: Emad A Rakha; Maysa E El-Sayed; Sindhu Menon; Andrew Green; Andrew H S Lee; Ian O Ellis
Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
Breast cancer research and treatment 2008;111(1):121-7.
2008: Abeer M Shaaban; Andrew Green; Suchita Karthik; Yalda Alizadeh; Thomas A Hughes; Lynn Harkins; Ian O Ellis; John F Robertson; Emma C Paish; Philippa Saunders; nigel P groome; Valerie Speirs
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5228-35.
2008: Angela A Luck; Andrew J Evans; Jonathan J James; Emad A Rakha; E Claire Paish; Andrew Green; Ian O Ellis
Breast carcinoma with basal phenotype: mammographic findings.
AJR. American journal of roentgenology 2008;191(2):346-51.
2008: Andrew Green; Claire Burney; Christopher J Granger; E Claire Paish; Somaia El-Sheikh; Emad A Rakha; Desmond G Powe; R Douglas Macmillan; Ian O Ellis; Eleni Stylianou
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
Breast cancer research and treatment 2008;110(3):427-37.
2008: S E Elsheikh; Andrew Green; E A Rakha; R M Samaka; A A Ammar; D Powe; Jorge S Reis-Filho; Ian O Ellis
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.
British journal of cancer 2008;99(2):327-34.
2008: Emad A Rakha; Somaia E El-Sheikh; Mona A Kandil; Maysa E El-Sayed; Andrew Green; Ian O Ellis
Expression of BRCA1 protein in breast cancer and its prognostic significance.
Human pathology 2008;39(6):857-65.
2008: Somaia Elsheikh; Andrew Green; Mohammed Aleskandarany; Matthew Grainge; Claire E Paish; Maryou B K Lambros; Jorge S Reis-Filho; Ian O Ellis
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Breast cancer research and treatment 2008;109(2):325-35.
2008: A A Luck; Andrew J Evans; Andrew Green; Emad A Rakha; Claire E Paish; Ian O Ellis
The influence of basal phenotype on the metastatic pattern of breast cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2008;20(1):40-5.
2008: Thomas R Fanshawe; Andrew G Lynch; Ian O Ellis; Andrew Green; Rudolf Hanka
Assessing agreement between multiple raters with missing rating information, applied to breast cancer tumour grading.
PloS one 2008;3(8):e2925.
2008: Emad A Rakha; Maysa E El-Sayed; Desmond G Powe; Andrew Green; Hany Habashy; Matthew J Grainge; John F R Robertson; Roger W Blamey; Julia Gee; Robert I Nicholson; Andrew H S Lee; Ian O Ellis
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
European journal of cancer (Oxford, England : 1990) 2008;44(1):73-83.
2007: Rabab A A Mohammed; Stewart Graham Martin; Muhammad S Gill; Andrew Green; Emma C Paish; Ian O Ellis
Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
The American journal of surgical pathology 2007;31(12):1825-33.
2007: Dirk Wienke; Gareth C Davies; Damian A Johnson; Justin Sturge; Maryou B K Lambros; Kay Savage; Somaia Elbauomy Elsheikh; Andrew Green; Ian O Ellis; David Robertson; Jorge S Reis-Filho; Clare M Isacke
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
Cancer research 2007;67(21):10230-40.
2007: Emad A Rakha; Maysa E El-Sayed; Andrew Green; E Claire Paish; Desmond G Powe; Julia Gee; Robert I Nicholson; Andrew H S Lee; John F R Robertson; Ian O Ellis
Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4772-8.
2007: Emad A Rakha; Maysa E El-Sayed; Andrew Green; E Claire Paish; Andrew H S Lee; Ian O Ellis
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.
Histopathology 2007;50(4):434-8.
2007: Andrew J Evans; Emad A Rakha; Sarah Elizabeth Pinder; Andrew Green; Claire E Paish; Ian O Ellis
Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
Journal of medical screening 2007;14(4):210-4.
2007: Suet-Feung Chin; Andrew E Teschendorff; John C Marioni; Yanzhong Wang; Nuno Barbosa-Morais; Natalie P Thorne; Jose L Costa; Sarah Elizabeth Pinder; Mark A van de Wiel; Andrew Green; Ian O Ellis; Peggy L Porter; Simon Tavaré; James D Brenton; Bauke Ylstra; Carlos Caldas
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
Genome biology 2007;8(10):R215.
2007: Somaia Elbauomy Elsheikh; Andrew Green; Maryou B K Lambros; Nicholas C Turner; Matthew J Grainge; Desmond G Powe; Ian O Ellis; Jorge S Reis-Filho
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.
Breast cancer research : BCR 2007;9(2):R23.
2007: Emad A Rakha; Maysa E El-Sayed; Andrew Green; Andrew H S Lee; John F R Robertson; Ian O Ellis
Prognostic markers in triple-negative breast cancer.
Cancer 2007;109(1):25-32.
2006: Emad A Rakha; Dalia Abd El-Rehim; Claire E Paish; Andrew Green; Andrew H S Lee; John F R Robertson; Roger W Blamey; Douglas Macmillan; Ian O Ellis
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
European journal of cancer (Oxford, England : 1990) 2006;42(18):3149-56.
2006: Emad A Rakha; Andrew Green; Des G Powe; Rebecca R Roylance; Ian O Ellis
Chromosome 16 tumor-suppressor genes in breast cancer.
Genes, chromosomes & cancer 2006;45(6):527-35.
2006: Nicholas F S Watson; Ian Spendlove; Zahra Madjd; Roger McGilvray; Andrew Green; Ian O Ellis; John H Scholefield; Lindy G Durrant
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.
International journal of cancer. Journal international du cancer 2006;118(6):1445-52.
2006: Emad A Rakha; Thomas C Putti; Dalia M Abd El-Rehim; Claire E Paish; Andrew Green; Des G Powe; Andrew H S Lee; John F R Robertson; Ian O Ellis
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
The Journal of pathology 2006;208(4):495-506.
2005: Emad A Rakha; Richard W G Boyce; Dalia M Abd El-Rehim; Thomas Kurien; Andrew Green; E Claire Paish; John F R Robertson; Ian O Ellis
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1295-304.
2005: T Kurien; R W G Boyce; E Claire Paish; J Ronan; J Maddison; Emad A Rakha; Andrew Green; Ian O Ellis
Three dimensional reconstruction of a human breast carcinoma using routine laboratory equipment and immunohistochemistry.
Journal of clinical pathology 2005;58(9):968-72.
2005: Andrew Green; Jerry A Styles; Emma L Parrott; Douglas Gray; Richard E Edwards; Andrew G Smith; Timothy W Gant; Peter Greaves; Farook Al-Azzawi; Ian N H White
Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.
Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie 2005;56(4-5):255-63.
2003: Andrew Green; Richard E Edwards; Peter Greaves; Ian N H White
Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factor-alpha expression in specific neonatal mouse uterine cell types using laser capture microdissection.
Journal of molecular endocrinology 2003;30(1):1-11.
2001: Andrew Green; Emma L Parrott; M Butterworth; P S Jones; Peter Greaves; Ian N H White
Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.
The Journal of endocrinology 2001;170(3):555-64.
1999: Valerie Speirs; Michael J Kerin; Christopher J Newton; DS Walton; Andrew Green; SB Desai; Stephen L Atkin
Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells.
International journal of oncology 1999;15(6):1251-4.
1999: D Chakravarthy; Andrew Green; Victoria L Green; Michael J Kerin; Valerie Speirs
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
International journal of oncology 1999;15(1):187-94.
1998: Valerie Speirs; Andrew Green; DS Walton; Michael J Kerin; John N Fox; PJ Carleton; SB Desai; Stephen L Atkin
Short-term primary culture of epithelial cells derived from human breast tumours.
British journal of cancer 1998;78(11):1421-9.
1998: V Speirs; Andrew Green; Stephen L Atkin
Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8.
The Journal of steroid biochemistry and molecular biology 1998;67(3):267-74.
1997: Andrew Green; Victoria L Green; MC White; Valerie Speirs
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours.
International journal of cancer. Journal international du cancer 1997;72(6):937-41.
1996: Valerie Speirs; Andrew Green; MC White
A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples.
International journal of cancer. Journal international du cancer 1996;66(4):551-6.
1996: V Speirs; M C White; Andrew Green
Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue.
In vitro cellular & developmental biology. Animal 1996;32(2):72-4.
1995: Valerie Speirs; M A Birch; E Boyle-Walsh; Andrew Green; J A Gallagher; MC White
Interleukin-3: a putative protective factor against breast cancer which is secreted by male but not female breast fibroblasts.
International journal of cancer. Journal international du cancer 1995;61(3):416-9.